Serum Ammonia Screening and Donor Mollicutes Detection for Hyperammonemia Syndrome Post–Lung Transplantation: A Prospective Observational Study.

Background Hyperammonemia syndrome (HS) is a rare but potentially fatal complication of lung transplantation (LT). Optimal screening methods are unknown. Here we investigated serum ammonia screening (SAS) for HS and compared it with polymerase chain reaction (PCR) for Mollicutes (Urease -producing b...

Descripción completa

Detalles Bibliográficos
Publicado en:Clinical Infectious Diseases Vol. 81; no. 5; pp. 998 - 1005
Autores principales: Walti, Laura N, Ng, Chun Fai, Kaur, Simran, Almansour, Sarah, Mazzulli, Tony, Bitterman, Roni, Sidhu, Aman, Keshavjee, Shaf, Chaparro, Cecilia, Martinu, Tereza
Formato: algorithm research tables/charts Journal Article
Publicado: Oxford University Press / USA 11/15/2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=190481280&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 190481280
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10584838
        46X
      jtl: Clinical Infectious Diseases
      issn: 10584838
      maglogo: N
    pubinfo:
      dt: 11/15/2025
      vid: 81
      iid: 5
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        190481280
        190481280
        190481280
        10.1093/cid/ciaf078
        190481280
      ppf: 998
      ppct: 7
      formats:
      tig:
        atl: Serum Ammonia Screening and Donor Mollicutes Detection for Hyperammonemia Syndrome Post–Lung Transplantation: A Prospective Observational Study.
      aug:
        au:
          Walti, Laura N
          Ng, Chun Fai
          Kaur, Simran
          Almansour, Sarah
          Mazzulli, Tony
          Bitterman, Roni
          Sidhu, Aman
          Keshavjee, Shaf
          Chaparro, Cecilia
          Martinu, Tereza
        affil: Transplant Infectious Diseases, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, CanadaDepartment of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
      sug:
        subj:
          Hyperammonemia Epidemiology
          Hyperammonemia Diagnosis
          Hyperammonemia Mortality
          Ammonia Blood
          Lung Transplantation Adverse Effects
          Gram-Negative Bacteria
          Polymerase Chain Reaction
          Funding Source
          Human
          Male
          Female
          Middle Age
          Aged
          Prospective Studies
          Nonexperimental Studies
          Comparative Studies
          ROC Curve
          Data Analysis Software
          Descriptive Statistics
          Postoperative Complications
          Bacterial Infections
          Transplant Donors
          Transplant Recipients
          Neurologic Manifestations
          Tissue Banks
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: Background Hyperammonemia syndrome (HS) is a rare but potentially fatal complication of lung transplantation (LT). Optimal screening methods are unknown. Here we investigated serum ammonia screening (SAS) for HS and compared it with polymerase chain reaction (PCR) for Mollicutes (Urease -producing bacteria). Methods All LT recipients from July 2019 to February 2020 and October 2021 to November 2022 with available donor bronchial wash samples from the LT biobank were included. Mollicutes PCR was performed using 2 commercially available kits. Daily ammonia serum levels were measured for the first 14 days. Recipients were prospectively followed for HS for 30 days post-LT. HS was defined by new neurological symptoms and the presence of elevated serum ammonia (>1 × >70 µmol/L). Results Of 241 LT recipients, 5 (2%) developed HS within the first month post-LT. Median time to HS was 8 (interquartile range, 5–10) days. All HS was diagnosed within the first 14 days post-LT, while daily SAS was in place. Ammonia was confirmed elevated (>1 × >70 µmol/L) in 4% (9/241) during follow-up; however, outside of HS, 4 were found to be related to liver disease. Donor and recipient Mollicutes PCR was positive in 8% (19/241) and 1% (1/72), respectively, at transplant. Donor Mollicutes PCR, in contrast to recipient Mollicutes PCR, was associated with HS but only in 2 of the 5 HS cases. No HS patient died within 90 days post-LT. Conclusions HS was a rare complication in our LT cohort. Daily post-LT SAS might add to early HS diagnosis and treatment and is potentially associated with improved outcome. Donor screening with Mollicutes PCR has limited predictive value for HS post-LT.
      pubtype: Academic Journal
      doctype:
        algorithm
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N